Onconic Therapeutics Inc. (KOSDAQ:476060)
South Korea · Delayed Price · Currency is KRW 14,730
-320 (-2.13%)
Sep 22, 2026, 3:30 PM KST
Onconic Therapeutics Market Cap
Onconic Therapeutics has a market cap or net worth of 683.39 billion as of September 22, 2026. Its market cap has increased by 36.96% in one year.
Market Cap
683.39B
Enterprise Value
621.04B
Revenue
82.17B
Ranking
n/a
PE Ratio
28.48
Stock Price
14,730.00
ChartMarket Cap Chart
Since December 19, 2024, Onconic Therapeutics's market cap has increased from 186.91B to 683.39B, an increase of 265.63%. That is a compound annual growth rate of 109.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 21, 2026 | 683.39B | -21.43% |
| Dec 30, 2025 | 869.78B | 392.69% |
| Dec 30, 2024 | 176.54B | -5.55% |
| Dec 19, 2024 | 186.91B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Orum Therapeutics | 812.31B |
| Pharmicell | 751.85B |
| Chabiotech | 740.02B |
| Komipharm International | 711.84B |
| Hyundai Bioscience | 656.22B |
| GI Innovation | 616.77B |
| Medy-Tox | 434.64B |
| GC Corp. | 433.96B |